Description:This volume serves as a progress report on cutting-edge research in the field of Alzheimer's Disease and other forms of dementia, but with an emphasis on topics that are applicable to clinical practice. In this latest installment, Serge Gauthier, Philip Scheltens and Jeffrey Cummings cover some of the emerging therapies for Alzheimer's Disease, including statins, GAG minetics, and immunotherapy, as well as the use of hormonal therapy and atypical anti-psychotic agents in the treatment of other related dementias. Chapters will also summarize the current understanding of the pathophysiology of mild cognitive impairment as well as research into tau pathologies.